Lacey, David L.
Amgen Incorporated,
United States
2025 Rank: 84428
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2313 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84428 | 96811 |
| Total Cites | 41142 | 43052 |
| H-index | 59 | 62 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 5816 | 5940 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 12806 | 13032 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24857 | 25546 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.69 |
| Self-Citation Percentage |
4.44%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2024 Rank: 77808
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2181 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77808 | 89582 |
| Total Cites | 40359 | 42323 |
| H-index | 60 | 63 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 5679 | 5803 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 12417 | 12641 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24312 | 25048 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.69 |
| Self-Citation Percentage |
4.64%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2023 Rank: 72246
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2061 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72246 | 83342 |
| Total Cites | 39195 | 41136 |
| H-index | 60 | 63 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 5532 | 5652 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 11948 | 12170 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 23429 | 24157 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.70 |
| Self-Citation Percentage |
4.72%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2022 Rank: 69913
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2059 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69913 | 80879 |
| Total Cites | 36994 | 38822 |
| H-index | 57 | 60 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 5321 | 5442 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 11231 | 11451 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21760 | 22410 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.73 |
| Self-Citation Percentage |
4.71%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2021 Rank: 66569
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1974 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66569 | 77528 |
| Total Cites | 35877 | 37693 |
| H-index | 57 | 59 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 5163 | 5282 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 10870 | 11089 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21079 | 21718 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.74 |
| Self-Citation Percentage |
4.82%
|
|
Lacey, David L.
Amgen Incorporated,
United States
2020 Rank: 59997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1799 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59997 | 70842 |
| Total Cites | 33984 | 35767 |
| H-index | 57 | 58 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 4893 | 5012 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 10142 | 10361 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19733 | 20353 |
| Ratio of Total Citations to Distinct Citing Papers | 1.72 | 1.76 |
| Self-Citation Percentage |
4.99%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.